Optimum Investment Advisors Alterity Therapeutics LTD Transaction History

Optimum Investment Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 17, 2022	SELL	$0.01 - $0.02 $9 - $18	-927 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$0.02 - $0.03 $18 - $27	927 New	927 $1,000
Q3 2020 Oct 06, 2020	SELL	$0.0 - $0.05 $0 - $50	-1,000 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$0.0 - $0.03 $0 - $30	1,000 New	1,000 $1,000

Ticker ATHE
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,114,600
Market Cap $149M
Description
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also...

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Optimum Investment Advisors with notifications on news.